PAUL D RUBIN
CIK 1210905 · Chief Medical Officer · last filed 2026-04-03
PAUL D RUBIN is a Chief Medical Officer who has filed 63 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for BIOA, was dated Apr 3, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $850.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$850.7K
3
63
-$2.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOA | Chief Medical Officer | 5,437 | $21.92 | $119.2K | -$1.46M | 8 | 2026-04-03 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | EVP, Research & Development | — | — | — | $0 | 3 | 2019-02-08 |
| XOMA | Sr. VP Clinical Dev. & CMO | 18,211 | $40.17 | $731.5K | -$1.01M | 46 | 2016-03-22 |
Recent Filings
63 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | BIOA | Mixed | — | -$112.5K | EDGAR |
| 2026-04-01 | BIOA | Notice (144) | −8,820 | -$157.1K | EDGAR |
| 2026-03-03 | BIOA | Mixed | — | -$115.4K | EDGAR |
| 2026-03-02 | BIOA | Notice (144) | −7,433 | -$148.9K | EDGAR |
| 2026-02-19 | BIOA | Grant (A) | — | $0 | EDGAR |
| 2026-02-03 | BIOA | Mixed | — | -$103.9K | EDGAR |
| 2026-02-02 | BIOA | Notice (144) | −7,433 | -$139.4K | EDGAR |
| 2026-01-06 | BIOA | Mixed | — | -$60.0K | EDGAR |
| 2026-01-02 | BIOA | Notice (144) | −7,433 | -$99.7K | EDGAR |
| 2025-12-11 | BIOA | Mixed | — | -$97.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.